ProCE Banner Activity

Management of Neuropsychiatric Features in Alzheimer’s Disease Dementia

Slideset

This presentation will discuss how to recognize the psychiatric symptoms associated with dementia, the on-label and off-label medications and strategies used in Alzheimer’s disease psychosis, and dementia-related psychosis, and new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

Released: September 19, 2022

Expiration: September 18, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Marwan Sabbagh

Marwan Sabbagh, MD, FAAN

Professor of Neurology
Alzheimer s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Independent Educational Activity

Faculty Disclosure

Primary Author

Marwan Sabbagh, MD, FAAN

Professor of Neurology
Alzheimer s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona

Marwan Sabbagh, MD, FAAN: consultant/advisor/speaker: Alzheon, Biogen, Eisai, Genentech-Roche, KeifeRx, Lilly, NeuroTherapia, Novo Nordisk, Signant Health, Synaptogenix, T3D; ownership interest (stocks/stock options): Athira, Cortexyme/Quince Therapeutics, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Seq BioMarque, TransDermix, uMethod Health, Versanum; royalties or patent beneficiary: Humanix.